Studies suggest the gut microbiome can influence immunotherapy side effects. Butyrate emerges as an intriguing candidate against inflammation in the colon.
Crohn's and Colitis
A tiny arms race playing out inside the gut could eventually offer a new way to treat out-of-balance microbiomes.
Children and young adults with the inflammatory bowel disease may be less likely to develop perianal fistulas if they receive steroid-sparing therapies.